FDA Brief

Company record

Sarfez Pharmaceuticals, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Sarfez Pharmaceuticals, Inc..

Warning letters

  1. Sarfez Pharmaceuticals, Inc.

    FDA says Sarfez made false or misleading efficacy and risk claims for Soaanz (torsemide) in webpages, pamphlet, and exhibit panel.

    High risk